{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:01:49Z","timestamp":1762459309522,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ghir.2015.07.009","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T10:14:49Z","timestamp":1438251289000},"page":"298-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Improved glycemic control due to sitagliptin is not related to cortisol or the surrogate marker IGFBP-1 for hepatic insulin sensitivity"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7607-7715","authenticated-orcid":false,"given":"Lisa","family":"Arnetz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Hage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neda Rajamand","family":"Ekberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Alvarsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Brismar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Norhammar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Mellbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ghir.2015.07.009_bb0005","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/diacare.15.3.318","article-title":"Pathogenesis of NIDDM: a balanced overview","volume":"15","author":"DeFronzo","year":"1992","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.ghir.2015.07.009_bb0010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<427::AID-DMRR68>3.0.CO;2-C","article-title":"Neuroendocrine perturbations as a cause of insulin resistance","volume":"15","author":"Bjorntorp","year":"1999","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"11","key":"10.1016\/j.ghir.2015.07.009_bb0015","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1172\/JCI66180","article-title":"New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it","volume":"122","author":"Ferris","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.ghir.2015.07.009_bb0020","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0022-2275(20)41151-4","article-title":"Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes","volume":"35","author":"Slavin","year":"1994","journal-title":"J. Lipid Res."},{"issue":"12","key":"10.1016\/j.ghir.2015.07.009_bb0025","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/0026-0495(94)90010-8","article-title":"Changes in body composition and adipose tissue distribution after treatment of women with Cushing's syndrome","volume":"43","author":"Lonn","year":"1994","journal-title":"Metab. Clin. Exp."},{"issue":"5","key":"10.1016\/j.ghir.2015.07.009_bb0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1464-5491.1999.00067.x","article-title":"Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus","volume":"16","author":"Bjorntorp","year":"1999","journal-title":"Diabet. Med."},{"issue":"3\u20134","key":"10.1016\/j.ghir.2015.07.009_bb0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000095523","article-title":"The role of insulin-like growth factor binding proteins","volume":"83","author":"Holly","year":"2006","journal-title":"Neuroendocrinology"},{"issue":"12","key":"10.1016\/j.ghir.2015.07.009_bb0040","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1210\/jc.2008-1245","article-title":"Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivity","volume":"93","author":"Kotronen","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.07.009_bb0045","article-title":"Delta insulin-like growth factor binding protein-1 (DeltaIGFBP-1): a marker of hepatic insulin resistance?","author":"Borai","year":"2013","journal-title":"Ann. Clin. Biochem."},{"issue":"28","key":"10.1016\/j.ghir.2015.07.009_bb0050","doi-asserted-by":"crossref","first-page":"18868","DOI":"10.1016\/S0021-9258(18)55144-9","article-title":"Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1","volume":"266","author":"Powell","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ghir.2015.07.009_bb0055","first-page":"11","article-title":"Dexamethasone stimulates expression of insulin-like growth factor binding protein-1 in HEP G2 human hepatoma cells","volume":"3","author":"Powell","year":"1993","journal-title":"Growth Regul."},{"issue":"5","key":"10.1016\/j.ghir.2015.07.009_bb0060","first-page":"1142","article-title":"Glucagon stimulates insulin-like growth factor binding protein-1 secretion in healthy subjects, patients with pituitary insufficiency, and patients with insulin-dependent diabetes mellitus","volume":"77","author":"Hilding","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ghir.2015.07.009_bb0065","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3181\/00379727-216-44182","article-title":"Insulin-like growth factor binding protein-1: recent findings and new directions","volume":"216","author":"Lee","year":"1997","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"7","key":"10.1016\/j.ghir.2015.07.009_bb0070","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/0026-0495(91)90092-B","article-title":"The insulin-like growth factor binding protein-1 in low and high insulin responders before and during dexamethasone treatment","volume":"40","author":"Brismar","year":"1991","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.ghir.2015.07.009_bb0075","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/joim.12032","article-title":"Sitagliptin improves beta-cell function in patients with acute coronary syndromes and newly diagnosed glucose abnormalities-the BEGAMI study","volume":"273","author":"Hage","year":"2013","journal-title":"J. Intern. Med."},{"issue":"5","key":"10.1016\/j.ghir.2015.07.009_bb0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF03345195","article-title":"Hypothalamo\u2013pituitary\u2013adrenal axis in acute myocardial infarction treated by percutaneous transluminal coronary angioplasty: effect of time of presentation","volume":"26","author":"Paganelli","year":"2003","journal-title":"J. Endocrinol. Investig."},{"issue":"6","key":"10.1016\/j.ghir.2015.07.009_bb0085","first-page":"620","article-title":"Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand","volume":"124","author":"Bang","year":"1991","journal-title":"Acta Endocrinol. (Copenh)"},{"issue":"6","key":"10.1016\/j.ghir.2015.07.009_bb0090","first-page":"2013","article-title":"Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19\u201382 years, in relation to those in healthy subjects","volume":"84","author":"Hilding","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2015.07.009_bb0095","first-page":"563","article-title":"Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid","volume":"107","author":"Povoa","year":"1984","journal-title":"Acta Endocrinol. (Copenh)"},{"author":"(NGSP) NGSP","key":"10.1016\/j.ghir.2015.07.009_bb0100"},{"issue":"2","key":"10.1016\/j.ghir.2015.07.009_bb0105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/EJE-10-0301","article-title":"IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women","volume":"163","author":"Lewitt","year":"2010","journal-title":"Eur. J. Endocrinol."},{"issue":"7","key":"10.1016\/j.ghir.2015.07.009_bb0110","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s00125-008-1016-x","article-title":"Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men","volume":"51","author":"Lewitt","year":"2008","journal-title":"Diabetologia"},{"issue":"52","key":"10.1016\/j.ghir.2015.07.009_bb0115","doi-asserted-by":"crossref","first-page":"40236","DOI":"10.1074\/jbc.M608048200","article-title":"Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism","volume":"281","author":"Schweiger","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2015.07.009_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2840-10-21","article-title":"Value of oral glucose tolerance test in the acute phase of myocardial infarction","volume":"10","author":"Bronisz","year":"2011","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ghir.2015.07.009_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2840-8-6","article-title":"Abnormal glucose regulation in patients with acute ST-elevation myocardial infarction\u2014a cohort study on 224 patients","volume":"8","author":"Knudsen","year":"2009","journal-title":"Cardiovasc. Diabetol."},{"issue":"10","key":"10.1016\/j.ghir.2015.07.009_bb0130","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00392-008-0674-5","article-title":"Screening for undiagnosed diabetes in patients with acute myocardial infarction","volume":"97","author":"Lankisch","year":"2008","journal-title":"Clin. Res. Cardiol."},{"issue":"3","key":"10.1016\/j.ghir.2015.07.009_bb0135","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.diabres.2008.08.016","article-title":"Temporal change in glucose tolerance in non-ST-elevation myocardial infarction","volume":"82","author":"Srinivas-Shankar","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.ghir.2015.07.009_bb0140","article-title":"Improved insulin sensitivity during pioglitazone treatment is associated with changes in IGF-I and cortisol secretion in type 2 diabetes and impaired glucose tolerance","volume":"1","author":"Arnetz","year":"2013","journal-title":"ISRN Endocrinol."},{"key":"10.1016\/j.ghir.2015.07.009_bb0145","article-title":"Gender differences in non-glycemic responses to improved insulin sensitivity by pioglitazone treatment in patients with type 2 diabetes","volume":"1\u20138","author":"Arnetz","year":"2013","journal-title":"Acta Diabetol."},{"issue":"4","key":"10.1016\/j.ghir.2015.07.009_bb0150","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2796.2004.01371.x","article-title":"Abnormal glucose tolerance \u2014 a common risk factor in patients with acute myocardial infarction in comparison with population-based controls","volume":"256","author":"Bartnik","year":"2004","journal-title":"J. Intern. Med."},{"issue":"5","key":"10.1016\/j.ghir.2015.07.009_bb0155","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1365-2796.2003.01221.x","article-title":"Basal glucometabolic status has an impact on long-term prognosis following an acute myocardial infarction in non-diabetic patients","volume":"254","author":"Tenerz","year":"2003","journal-title":"J. Intern. Med."},{"issue":"9","key":"10.1016\/j.ghir.2015.07.009_bb0160","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.2337\/dc12-2072","article-title":"Mechanisms of glucose lowering of dipeptidyl peptidase-4 inhibitor sitagliptin when used alone or with metformin in type 2 diabetes: a double-tracer study","volume":"36","author":"Solis-Herrera","year":"2013","journal-title":"Diabetes Care"},{"issue":"2\u20133","key":"10.1016\/j.ghir.2015.07.009_bb0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ghir.2014.01.003","article-title":"GLP-1 infusion reduces IGFBP-1 serum level in humans","volume":"24","author":"Skov","year":"2014","journal-title":"Growth Hormon. IGF Res."},{"issue":"2\u20134","key":"10.1016\/j.ghir.2015.07.009_bb0170","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0955-2235(96)00006-3","article-title":"Regulation of IGFBP-1 in humans","volume":"6","author":"Brismar","year":"1995","journal-title":"Prog. Growth Factor Res."},{"issue":"8","key":"10.1016\/j.ghir.2015.07.009_bb0175","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/BF03350189","article-title":"Insulin regulates the 35kDa IGF binding protein in patients with diabetes mellitus","volume":"11","author":"Brismar","year":"1988","journal-title":"J. Endocrinol. Investig."},{"issue":"8","key":"10.1016\/j.ghir.2015.07.009_bb0180","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1210\/jcem.82.8.4167","article-title":"Influence of circulating epinephrine and norepinephrine on insulin-like growth factor binding protein-1 in humans","volume":"82","author":"Fernqvist-Forbes","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2015.07.009_bb0185","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"issue":"8","key":"10.1016\/j.ghir.2015.07.009_bb0190","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1210\/jcem.86.8.7778","article-title":"Chronic insomnia is associated with nyctohemeral activation of the hypothalamic\u2013pituitary\u2013adrenal axis: clinical implications","volume":"86","author":"Vgontzas","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ghir.2015.07.009_bb0195","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/cs0960513","article-title":"Glucocorticoids and insulin resistance: old hormones, new targets","volume":"96","author":"Andrews","year":"1999","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.ghir.2015.07.009_bb0200","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1677\/joe.0.1750099","article-title":"Plasma binding proteins as mediators of corticosteroid action in vertebrates","volume":"175","author":"Breuner","year":"2002","journal-title":"J. Endocrinol."},{"issue":"7","key":"10.1016\/j.ghir.2015.07.009_bb0205","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s007020070062","article-title":"Salivary, total plasma and plasma free cortisol in panic disorder","volume":"107","author":"Wedekind","year":"2000","journal-title":"J. Neural Transm."},{"issue":"10","key":"10.1016\/j.ghir.2015.07.009_bb0210","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1053\/meta.2001.25647","article-title":"Study of the effect of changing glucose, insulin, and insulin-like growth factor-I levels on serum corticosteroid binding globulin in lean, obese, and obese subjects with glucose intolerance","volume":"50","author":"Fernandez-Real","year":"2001","journal-title":"Metabolism"}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637415300204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637415300204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:49:12Z","timestamp":1761086952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637415300204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1096637415300204"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2015.07.009","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved glycemic control due to sitagliptin is not related to cortisol or the surrogate marker IGFBP-1 for hepatic insulin sensitivity","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2015.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}